Department of Medicine, University of California, San Francisco, CA, USA.
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Am J Transplant. 2018 Aug;18(8):1995-2004. doi: 10.1111/ajt.14873. Epub 2018 May 14.
Frailty is associated with increased mortality among lung transplant candidates. We sought to determine the association between frailty, as measured by the Short Physical Performance Battery (SPPB), and mortality after lung transplantation. In a multicenter prospective cohort study of adults who underwent lung transplantation, preoperative frailty was assessed with the SPPB (n = 318) and, in a secondary analysis, the Fried Frailty Phenotype (FFP; n = 299). We tested the association between preoperative frailty and mortality following lung transplantation with propensity score-adjusted Cox models. We calculated postestimation marginalized standardized risks for 1-year mortality by frailty status using multivariate logistic regression. SPPB frailty was associated with an increased risk of both 1- and 4-year mortality (adjusted hazard ratio [aHR]: 7.5; 95% confidence interval [CI]: 1.6-36.0 and aHR 3.8; 95%CI: 1.8-8.0, respectively). Each 1-point worsening in SPPB was associated with a 20% increased risk of death (aHR: 1.20; 95%CI: 1.08-1.33). Frail subjects had an absolute increased risk of death within the first year after transplantation of 12.2% (95%CI: 3.1%-21%). In secondary analyses, FFP frailty was associated with increased risk of death within the first postoperative year (aHR: 3.8; 95%CI: 1.1-13.2) but not over longer follow-up. Preoperative frailty is associated with an increased risk of death after lung transplantation.
衰弱与肺移植候选者的死亡率增加有关。我们旨在确定通过短体物理表现电池(SPPB)测量的衰弱与肺移植后死亡率之间的关联。在一项对接受肺移植的成年人进行的多中心前瞻性队列研究中,使用 SPPB(n=318)和(在二次分析中)Fried 衰弱表型(FFP;n=299)评估术前衰弱。我们使用倾向评分调整的 Cox 模型测试了术前衰弱与肺移植后死亡率之间的关联。我们使用多元逻辑回归计算了根据脆弱状态的 1 年死亡率的后估计边缘标准化风险。SPPB 虚弱与 1 年和 4 年死亡率的增加风险相关(调整后的危险比 [aHR]:7.5;95%置信区间 [CI]:1.6-36.0 和 aHR 3.8;95%CI:1.8-8.0)。SPPB 每恶化 1 分,死亡风险增加 20%(aHR:1.20;95%CI:1.08-1.33)。虚弱患者在移植后第一年的绝对死亡风险增加了 12.2%(95%CI:3.1%-21%)。在二次分析中,FFP 衰弱与术后第一年死亡风险增加相关(aHR:3.8;95%CI:1.1-13.2),但在更长的随访中没有增加。术前衰弱与肺移植后死亡风险增加相关。